Skip to main content
Clinical Trials/IRCT2016020926489N1
IRCT2016020926489N1
Completed
Phase 3

Botulinum toxin type A effects on the treatment of keloid lesions; Comparison of intralesional two different doses

School of Medicine, Tehran University of Medical Sciences0 sites86 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Keloid Lesion.
Sponsor
School of Medicine, Tehran University of Medical Sciences
Enrollment
86
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
School of Medicine, Tehran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • patients with keloid lesion greater 2cm; patient age between 12\-65 years of old; patients consent to participate in the study;
  • Exclusion criteria: patients with keloid lesion smaller than 1\.9cm; lack of patient satisfaction in doing a research intervention; sensitivity to BTX\-A; pregnant and breastfeeding women; patients with neuromuscular diseases.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials